M Woisetschlaeger

Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR

Nicole Meisner‐Kober, Martin Hintersteiner, Kurt Mueller et al. · Nature Chemical Biology · 2007 · 226 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.

M Woisetschlaeger, Chandri Yandava, L A Furmanski et al. · Proceedings of the National Academy of Sciences · 1990 · 196 citations

Life Sciences, Molecular Biology, Molecular Genetics +15

Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.

M Woisetschlaeger, Xian Jin, C N Yandava et al. · Proceedings of the National Academy of Sciences · 1991 · 137 citations

Life Sciences, Genetics, Molecular Biology +13

Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes.

M Woisetschlaeger, Jack L. Strominger, Samuel H. Speck · Proceedings of the National Academy of Sciences · 1989 · 119 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.

Brian C. Schaefer, M Woisetschlaeger, Jack L. Strominger et al. · Proceedings of the National Academy of Sciences · 1991 · 107 citations

Life Sciences, Cell Biology, Molecular Biology +14